分子インフルエンザ診断の世界市場 2020年：企業別、地域別、種類・用途別

• 英文タイトル：Global Molecular Influenza Diagnostic Market 2020 by Company, Regions, Type and Application, Forecast to 2025

• レポートコード：D0804-16101 • 出版社/出版日：GlobalInfoResearch / 2020年7月28日 ※2025年版があります。お問い合わせください。 • レポート形態：英語、PDF、100ページ • 納品方法：Eメール • 産業分類：医療機器・医療消耗品

• 販売価格（消費税別）

Single User	￥487,200 (USD3,480)	▷ お問い合わせ
Multi User	￥730,800 (USD5,220)	▷ お問い合わせ
Corporate User	￥974,400 (USD6,960)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

本調査レポートでは、分子インフルエンザ診断の世界市場を広く調査・分析し、今後の市場展望をまとめております。分子インフルエンザ診断の種類別市場規模（逆転写ポリメラーゼ連鎖反応（RT-PCR）、核酸シーケンスベース増幅（NASBA）テスト、ループ介在増幅ベースアッセイ（LAMP）、シンプル増幅ベースアッセイ（SAMBA））、用途別市場規模（病院、POCT、その他）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェアなどの情報を掲載しています。 ・市場概要 ・企業情報（販売量、市場シェア、製品概要、SWOT分析）：BD、Meridian Bioscience、SIEMENS、Abbott (Include Alere)、Thermo Fisher、Roche、Sekisui Diagnostics、Quidel、Analytik Jena、BioMerieux、Response Biomedical、SA Scientific ・地域別グローバル市場分析 2015年-2020年 ・分子インフルエンザ診断の北米市場（アメリカ、カナダ、メキシコ） ・分子インフルエンザ診断のヨーロッパ市場（ドイツ、イギリス、フランス、ロシア、イタリア） ・分子インフルエンザ診断のアジア市場（中国、日本、韓国、インド、東南アジア、オーストラリア） ・分子インフルエンザ診断の南米市場（ブラジル、アルゼンチン） ・分子インフルエンザ診断の中東・アフリカ市場（サウジアラビア、トルコ、エジプト、南アフリカ） ・種類別分析：逆転写ポリメラーゼ連鎖反応（RT-PCR）、核酸シーケンスベース増幅（NASBA）テスト、ループ介在増幅ベースアッセイ（LAMP）、シンプル増幅ベースアッセイ（SAMBA） ・用途別分析：病院、POCT、その他 ・地域別市場規模予測 2021年-2025年 ・調査の結果・結論

Market Overview
The global Molecular Influenza Diagnostic market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019.

The Molecular Influenza Diagnostic market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

Market segmentation
Molecular Influenza Diagnostic market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.

By Type, Molecular Influenza Diagnostic market has been segmented into:
Reverse Transcription Polymerase Chain Reaction (RT-PCR)
Nucleic Acid Sequence Based Amplification (NASBA) Tests
Loop-mediated Isothermal Amplification-Based Assays (LAMP)
Simple Amplification-based Assays (SAMBA)

By Application, Molecular Influenza Diagnostic has been segmented into:
Hospitals
POCT
Others

Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Molecular Influenza Diagnostic market presented in the report. This section sheds light on the sales growth of different regional and country-level Molecular Influenza Diagnostic markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Molecular Influenza Diagnostic market.

The report offers in-depth assessment of the growth and other aspects of the Molecular Influenza Diagnostic market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Australia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Competitive Landscape and Molecular Influenza Diagnostic Market Share Analysis
Molecular Influenza Diagnostic competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Molecular Influenza Diagnostic sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Molecular Influenza Diagnostic sales, revenue and market share for each player covered in this report.

The major players covered in Molecular Influenza Diagnostic are:
BD
Meridian Bioscience
SIEMENS
Abbott (Include Alere)
Thermo Fisher
Roche
Sekisui Diagnostics
Quidel
Analytik Jena
BioMerieux
Response Biomedical
SA Scientific

レポート目次

---

Table of Contents

1 Molecular Influenza Diagnostic Market Overview
1.1 Product Overview and Scope of Molecular Influenza Diagnostic
1.2 Classification of Molecular Influenza Diagnostic by Type
1.2.1 Global Molecular Influenza Diagnostic Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Global Molecular Influenza Diagnostic Revenue Market Share by Type in 2019
1.2.3 Reverse Transcription Polymerase Chain Reaction (RT-PCR)
1.2.4 Nucleic Acid Sequence Based Amplification (NASBA) Tests
1.2.5 Loop-mediated Isothermal Amplification-Based Assays (LAMP)
1.2.6 Simple Amplification-based Assays (SAMBA)
1.3 Global Molecular Influenza Diagnostic Market by Application
1.3.1 Overview: Global Molecular Influenza Diagnostic Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Hospitals
1.3.3 POCT
1.3.4 Others
1.4 Global Molecular Influenza Diagnostic Market by Regions
1.4.1 Global Molecular Influenza Diagnostic Market Size by Regions: 2015 VS 2019 VS 2025
1.4.2 Global Market Size of Molecular Influenza Diagnostic (2015-2025)
1.4.3 North America (USA, Canada and Mexico) Molecular Influenza Diagnostic Status and Prospect (2015-2025)
1.4.4 Europe (Germany, France, UK, Russia and Italy) Molecular Influenza Diagnostic Status and Prospect (2015-2025)
1.4.5 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Molecular Influenza Diagnostic Status and Prospect (2015-2025)
1.4.6 South America (Brazil, Argentina, Colombia) Molecular Influenza Diagnostic Status and Prospect (2015-2025)
1.4.7 Middle East & Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Molecular Influenza Diagnostic Status and Prospect (2015-2025)
2 Company Profiles
2.1 BD
2.1.1 BD Details
2.1.2 BD Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 BD SWOT Analysis
2.1.4 BD Product and Services
2.1.5 BD Molecular Influenza Diagnostic Revenue, Gross Margin and Market Share (2018-2019)
2.2 Meridian Bioscience
2.2.1 Meridian Bioscience Details
2.2.2 Meridian Bioscience Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 Meridian Bioscience SWOT Analysis
2.2.4 Meridian Bioscience Product and Services
2.2.5 Meridian Bioscience Molecular Influenza Diagnostic Revenue, Gross Margin and Market Share (2018-2019)
2.3 SIEMENS
2.3.1 SIEMENS Details
2.3.2 SIEMENS Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 SIEMENS SWOT Analysis
2.3.4 SIEMENS Product and Services
2.3.5 SIEMENS Molecular Influenza Diagnostic Revenue, Gross Margin and Market Share (2018-2019)
2.4 Abbott (Include Alere)
2.4.1 Abbott (Include Alere) Details
2.4.2 Abbott (Include Alere) Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 Abbott (Include Alere) SWOT Analysis
2.4.4 Abbott (Include Alere) Product and Services
2.4.5 Abbott (Include Alere) Molecular Influenza Diagnostic Revenue, Gross Margin and Market Share (2018-2019)
2.5 Thermo Fisher
2.5.1 Thermo Fisher Details
2.5.2 Thermo Fisher Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 Thermo Fisher SWOT Analysis
2.5.4 Thermo Fisher Product and Services
2.5.5 Thermo Fisher Molecular Influenza Diagnostic Revenue, Gross Margin and Market Share (2018-2019)
2.6 Roche
2.6.1 Roche Details
2.6.2 Roche Major Business and Total Revenue (Financial Highlights) Analysis
2.6.3 Roche SWOT Analysis
2.6.4 Roche Product and Services
2.6.5 Roche Molecular Influenza Diagnostic Revenue, Gross Margin and Market Share (2018-2019)
2.7 Sekisui Diagnostics
2.7.1 Sekisui Diagnostics Details
2.7.2 Sekisui Diagnostics Major Business and Total Revenue (Financial Highlights) Analysis
2.7.3 Sekisui Diagnostics SWOT Analysis
2.7.4 Sekisui Diagnostics Product and Services
2.7.5 Sekisui Diagnostics Molecular Influenza Diagnostic Revenue, Gross Margin and Market Share (2018-2019)
2.8 Quidel
2.8.1 Quidel Details
2.8.2 Quidel Major Business and Total Revenue (Financial Highlights) Analysis
2.8.3 Quidel SWOT Analysis
2.8.4 Quidel Product and Services
2.8.5 Quidel Molecular Influenza Diagnostic Revenue, Gross Margin and Market Share (2018-2019)
2.9 Analytik Jena
2.9.1 Analytik Jena Details
2.9.2 Analytik Jena Major Business and Total Revenue (Financial Highlights) Analysis
2.9.3 Analytik Jena SWOT Analysis
2.9.4 Analytik Jena Product and Services
2.9.5 Analytik Jena Molecular Influenza Diagnostic Revenue, Gross Margin and Market Share (2018-2019)
2.10 BioMerieux
2.10.1 BioMerieux Details
2.10.2 BioMerieux Major Business and Total Revenue (Financial Highlights) Analysis
2.10.3 BioMerieux SWOT Analysis
2.10.4 BioMerieux Product and Services
2.10.5 BioMerieux Molecular Influenza Diagnostic Revenue, Gross Margin and Market Share (2018-2019)
2.11 Response Biomedical
2.11.1 Response Biomedical Details
2.11.2 Response Biomedical Major Business and Total Revenue (Financial Highlights) Analysis
2.11.3 Response Biomedical SWOT Analysis
2.11.4 Response Biomedical Product and Services
2.11.5 Response Biomedical Molecular Influenza Diagnostic Revenue, Gross Margin and Market Share (2018-2019)
2.12 SA Scientific
2.12.1 SA Scientific Details
2.12.2 SA Scientific Major Business and Total Revenue (Financial Highlights) Analysis
2.12.3 SA Scientific SWOT Analysis
2.12.4 SA Scientific Product and Services
2.12.5 SA Scientific Molecular Influenza Diagnostic Revenue, Gross Margin and Market Share (2018-2019)
3 Market Competition, by Players
3.1 Global Molecular Influenza Diagnostic Revenue and Share by Players (2015-2020)
3.2 Market Concentration Rate
3.2.1 Top 5 Molecular Influenza Diagnostic Players Market Share
3.2.2 Top 10 Molecular Influenza Diagnostic Players Market Share
3.3 Market Competition Trend
4 Market Size by Regions
4.1 Global Molecular Influenza Diagnostic Revenue and Market Share by Regions
4.2 North America Molecular Influenza Diagnostic Revenue and Growth Rate (2015-2020)
4.3 Europe Molecular Influenza Diagnostic Revenue and Growth Rate (2015-2020)
4.4 Asia-Pacific Molecular Influenza Diagnostic Revenue and Growth Rate (2015-2020)
4.5 South America Molecular Influenza Diagnostic Revenue and Growth Rate (2015-2020)
4.6 Middle East & Africa Molecular Influenza Diagnostic Revenue and Growth Rate (2015-2020)
5 North America Molecular Influenza Diagnostic Revenue by Countries
5.1 North America Molecular Influenza Diagnostic Revenue by Countries (2015-2020)
5.2 USA Molecular Influenza Diagnostic Revenue and Growth Rate (2015-2020)
5.3 Canada Molecular Influenza Diagnostic Revenue and Growth Rate (2015-2020)
5.4 Mexico Molecular Influenza Diagnostic Revenue and Growth Rate (2015-2020)
6 Europe Molecular Influenza Diagnostic Revenue by Countries
6.1 Europe Molecular Influenza Diagnostic Revenue by Countries (2015-2020)
6.2 Germany Molecular Influenza Diagnostic Revenue and Growth Rate (2015-2020)
6.3 UK Molecular Influenza Diagnostic Revenue and Growth Rate (2015-2020)
6.4 France Molecular Influenza Diagnostic Revenue and Growth Rate (2015-2020)
6.5 Russia Molecular Influenza Diagnostic Revenue and Growth Rate (2015-2020)
6.6 Italy Molecular Influenza Diagnostic Revenue and Growth Rate (2015-2020)
7 Asia-Pacific Molecular Influenza Diagnostic Revenue by Countries
7.1 Asia-Pacific Molecular Influenza Diagnostic Revenue by Countries (2015-2020)
7.2 China Molecular Influenza Diagnostic Revenue and Growth Rate (2015-2020)
7.3 Japan Molecular Influenza Diagnostic Revenue and Growth Rate (2015-2020)
7.4 Korea Molecular Influenza Diagnostic Revenue and Growth Rate (2015-2020)
7.5 India Molecular Influenza Diagnostic Revenue and Growth Rate (2015-2020)
7.6 Southeast Asia Molecular Influenza Diagnostic Revenue and Growth Rate (2015-2020)
8 South America Molecular Influenza Diagnostic Revenue by Countries
8.1 South America Molecular Influenza Diagnostic Revenue by Countries (2015-2020)
8.2 Brazil Molecular Influenza Diagnostic Revenue and Growth Rate (2015-2020)
8.3 Argentina Molecular Influenza Diagnostic Revenue and Growth Rate (2015-2020)
9 Middle East & Africa Revenue Molecular Influenza Diagnostic by Countries
9.1 Middle East & Africa Molecular Influenza Diagnostic Revenue by Countries (2015-2020)
9.2 Saudi Arabia Molecular Influenza Diagnostic Revenue and Growth Rate (2015-2020)
9.3 UAE Molecular Influenza Diagnostic Revenue and Growth Rate (2015-2020)
9.4 Egypt Molecular Influenza Diagnostic Revenue and Growth Rate (2015-2020)
9.5 South Africa Molecular Influenza Diagnostic Revenue and Growth Rate (2015-2020)
10 Market Size Segment by Type
10.1 Global Molecular Influenza Diagnostic Revenue and Market Share by Type (2015-2020)
10.2 Global Molecular Influenza Diagnostic Market Forecast by Type (2019-2024)
10.3 Reverse Transcription Polymerase Chain Reaction (RT-PCR) Revenue Growth Rate (2015-2025)
10.4 Nucleic Acid Sequence Based Amplification (NASBA) Tests Revenue Growth Rate (2015-2025)
10.5 Loop-mediated Isothermal Amplification-Based Assays (LAMP) Revenue Growth Rate (2015-2025)
10.6 Simple Amplification-based Assays (SAMBA) Revenue Growth Rate (2015-2025)
11 Global Molecular Influenza Diagnostic Market Segment by Application
11.1 Global Molecular Influenza Diagnostic Revenue Market Share by Application (2015-2020)
11.2 Molecular Influenza Diagnostic Market Forecast by Application (2019-2024)
11.3 Hospitals Revenue Growth (2015-2020)
11.4 POCT Revenue Growth (2015-2020)
11.5 Others Revenue Growth (2015-2020)
12 Global Molecular Influenza Diagnostic Market Size Forecast (2021-2025)
12.1 Global Molecular Influenza Diagnostic Market Size Forecast (2021-2025)
12.2 Global Molecular Influenza Diagnostic Market Forecast by Regions (2021-2025)
12.3 North America Molecular Influenza Diagnostic Revenue Market Forecast (2021-2025)
12.4 Europe Molecular Influenza Diagnostic Revenue Market Forecast (2021-2025)
12.5 Asia-Pacific Molecular Influenza Diagnostic Revenue Market Forecast (2021-2025)
12.6 South America Molecular Influenza Diagnostic Revenue Market Forecast (2021-2025)
12.7 Middle East & Africa Molecular Influenza Diagnostic Revenue Market Forecast (2021-2025)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
14.3 Disclaimer
14.4 About US

List of Tables

Table 1. Global Molecular Influenza Diagnostic Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Molecular Influenza Diagnostic by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Molecular Influenza Diagnostic Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Global Market Molecular Influenza Diagnostic Revenue (Million USD) Comparison by Regions 2015-2025
Table 5. BD Corporate Information, Location and Competitors
Table 6. BD Molecular Influenza Diagnostic Major Business
Table 7. BD Molecular Influenza Diagnostic Total Revenue (USD Million) (2017-2018)
Table 8. BD SWOT Analysis
Table 9. BD Molecular Influenza Diagnostic Product and Solutions
Table 10. BD Molecular Influenza Diagnostic Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 11. Meridian Bioscience Corporate Information, Location and Competitors
Table 12. Meridian Bioscience Molecular Influenza Diagnostic Major Business
Table 13. Meridian Bioscience Molecular Influenza Diagnostic Total Revenue (USD Million) (2018-2019)
Table 14. Meridian Bioscience SWOT Analysis
Table 15. Meridian Bioscience Molecular Influenza Diagnostic Product and Solutions
Table 16. Meridian Bioscience Molecular Influenza Diagnostic Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 17. SIEMENS Corporate Information, Location and Competitors
Table 18. SIEMENS Molecular Influenza Diagnostic Major Business
Table 19. SIEMENS Molecular Influenza Diagnostic Total Revenue (USD Million) (2017-2018)
Table 20. SIEMENS SWOT Analysis
Table 21. SIEMENS Molecular Influenza Diagnostic Product and Solutions
Table 22. SIEMENS Molecular Influenza Diagnostic Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 23. Abbott (Include Alere) Corporate Information, Location and Competitors
Table 24. Abbott (Include Alere) Molecular Influenza Diagnostic Major Business
Table 25. Abbott (Include Alere) Molecular Influenza Diagnostic Total Revenue (USD Million) (2017-2018)
Table 26. Abbott (Include Alere) SWOT Analysis
Table 27. Abbott (Include Alere) Molecular Influenza Diagnostic Product and Solutions
Table 28. Abbott (Include Alere) Molecular Influenza Diagnostic Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 29. Thermo Fisher Corporate Information, Location and Competitors
Table 30. Thermo Fisher Molecular Influenza Diagnostic Major Business
Table 31. Thermo Fisher Molecular Influenza Diagnostic Total Revenue (USD Million) (2017-2018)
Table 32. Thermo Fisher SWOT Analysis
Table 33. Thermo Fisher Molecular Influenza Diagnostic Product and Solutions
Table 34. Thermo Fisher Molecular Influenza Diagnostic Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 35. Roche Corporate Information, Location and Competitors
Table 36. Roche Molecular Influenza Diagnostic Major Business
Table 37. Roche Molecular Influenza Diagnostic Total Revenue (USD Million) (2017-2018)
Table 38. Roche SWOT Analysis
Table 39. Roche Molecular Influenza Diagnostic Product and Solutions
Table 40. Roche Molecular Influenza Diagnostic Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 41. Sekisui Diagnostics Corporate Information, Location and Competitors
Table 42. Sekisui Diagnostics Molecular Influenza Diagnostic Major Business
Table 43. Sekisui Diagnostics Molecular Influenza Diagnostic Total Revenue (USD Million) (2017-2018)
Table 44. Sekisui Diagnostics SWOT Analysis
Table 45. Sekisui Diagnostics Molecular Influenza Diagnostic Product and Solutions
Table 46. Sekisui Diagnostics Molecular Influenza Diagnostic Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 47. Quidel Corporate Information, Location and Competitors
Table 48. Quidel Molecular Influenza Diagnostic Major Business
Table 49. Quidel Molecular Influenza Diagnostic Total Revenue (USD Million) (2017-2018)
Table 50. Quidel SWOT Analysis
Table 51. Quidel Molecular Influenza Diagnostic Product and Solutions
Table 52. Quidel Molecular Influenza Diagnostic Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 53. Analytik Jena Corporate Information, Location and Competitors
Table 54. Analytik Jena Molecular Influenza Diagnostic Major Business
Table 55. Analytik Jena Molecular Influenza Diagnostic Total Revenue (USD Million) (2017-2018)
Table 56. Analytik Jena SWOT Analysis
Table 57. Analytik Jena Molecular Influenza Diagnostic Product and Solutions
Table 58. Analytik Jena Molecular Influenza Diagnostic Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 59. BioMerieux Corporate Information, Location and Competitors
Table 60. BioMerieux Molecular Influenza Diagnostic Major Business
Table 61. BioMerieux Molecular Influenza Diagnostic Total Revenue (USD Million) (2017-2018)
Table 62. BioMerieux SWOT Analysis
Table 63. BioMerieux Molecular Influenza Diagnostic Product and Solutions
Table 64. BioMerieux Molecular Influenza Diagnostic Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 65. Response Biomedical Corporate Information, Location and Competitors
Table 66. Response Biomedical Molecular Influenza Diagnostic Major Business
Table 67. Response Biomedical Molecular Influenza Diagnostic Total Revenue (USD Million) (2017-2018)
Table 68. Response Biomedical SWOT Analysis
Table 69. Response Biomedical Molecular Influenza Diagnostic Product and Solutions
Table 70. Response Biomedical Molecular Influenza Diagnostic Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 71. SA Scientific Corporate Information, Location and Competitors
Table 72. SA Scientific Molecular Influenza Diagnostic Major Business
Table 73. SA Scientific Molecular Influenza Diagnostic Total Revenue (USD Million) (2017-2018)
Table 74. SA Scientific SWOT Analysis
Table 75. SA Scientific Molecular Influenza Diagnostic Product and Solutions
Table 76. SA Scientific Molecular Influenza Diagnostic Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 77. Global Molecular Influenza Diagnostic Revenue (Million USD) by Players (2015-2020)
Table 78. Global Molecular Influenza Diagnostic Revenue Share by Players (2015-2020)
Table 79. Global Molecular Influenza Diagnostic Revenue (Million USD) by Regions (2015-2020)
Table 80. Global Molecular Influenza Diagnostic Revenue Market Share by Regions (2015-2020)
Table 81. North America Molecular Influenza Diagnostic Revenue by Countries (2015-2020)
Table 82. North America Molecular Influenza Diagnostic Revenue Market Share by Countries (2015-2020)
Table 83. Europe Molecular Influenza Diagnostic Revenue (Million USD) by Countries (2015-2020)
Table 84. Asia-Pacific Molecular Influenza Diagnostic Revenue (Million USD) by Countries (2015-2020)
Table 85. South America Molecular Influenza Diagnostic Revenue by Countries (2015-2020)
Table 86. South America Molecular Influenza Diagnostic Revenue Market Share by Countries (2015-2020)
Table 87. Middle East and Africa Molecular Influenza Diagnostic Revenue (Million USD) by Countries (2015-2020)
Table 88. Middle East and Africa Molecular Influenza Diagnostic Revenue Market Share by Countries (2015-2020)
Table 89. Global Molecular Influenza Diagnostic Revenue (Million USD) by Type (2015-2020)
Table 90. Global Molecular Influenza Diagnostic Revenue Share by Type (2015-2020)
Table 91. Global Molecular Influenza Diagnostic Revenue Forecast by Type (2021-2025)
Table 92. Global Molecular Influenza Diagnostic Revenue by Application (2015-2020)
Table 93. Global Molecular Influenza Diagnostic Revenue Share by Application (2015-2020)
Table 94. Global Molecular Influenza Diagnostic Revenue Forecast by Application (2021-2025)
Table 95. Global Molecular Influenza Diagnostic Revenue (Million USD) Forecast by Regions (2021-2025)
List of Figures
Figure 1. Molecular Influenza Diagnostic Picture
Figure 2. Global Molecular Influenza Diagnostic Revenue Market Share by Type in 2019
Figure 3. Reverse Transcription Polymerase Chain Reaction (RT-PCR) Picture
Figure 4. Nucleic Acid Sequence Based Amplification (NASBA) Tests Picture
Figure 5. Loop-mediated Isothermal Amplification-Based Assays (LAMP) Picture
Figure 6. Simple Amplification-based Assays (SAMBA) Picture
Figure 7. Molecular Influenza Diagnostic Revenue Market Share by Application in 2019
Figure 8. Hospitals Picture
Figure 9. POCT Picture
Figure 10. Others Picture
Figure 11. Global Molecular Influenza Diagnostic Revenue (USD Million) and Growth Rate (2015-2025)
Figure 12. North America Molecular Influenza Diagnostic Revenue (Million USD) and Growth Rate (2015-2025)
Figure 13. Europe Molecular Influenza Diagnostic Revenue (Million USD) and Growth Rate (2015-2025)
Figure 14. Asia-Pacific Molecular Influenza Diagnostic Revenue (Million USD) and Growth Rate (2015-2025)
Figure 15. South America Molecular Influenza Diagnostic Revenue (Million USD) and Growth Rate (2015-2025)
Figure 16. Middle East and Africa Molecular Influenza Diagnostic Revenue (Million USD) and Growth Rate (2015-2025)
Figure 17. Global Molecular Influenza Diagnostic Revenue (Million USD) and Growth Rate (2015-2025)
Figure 18. Global Molecular Influenza Diagnostic Revenue Share by Players in 2019
Figure 19. Global Top 5 Players Molecular Influenza Diagnostic Revenue Market Share in 2019
Figure 20. Global Top 10 Players Molecular Influenza Diagnostic Revenue Market Share in 2019
Figure 21. Key Players Market Share Trend
Figure 22. Global Molecular Influenza Diagnostic Revenue (Million USD) and Growth Rate (%) (2015-2020)
Figure 23. Global Molecular Influenza Diagnostic Revenue Market Share by Regions (2015-2020)
Figure 24. Global Molecular Influenza Diagnostic Revenue Market Share by Regions in 2018
Figure 25. North America Molecular Influenza Diagnostic Revenue and Growth Rate (2015-2020)
Figure 26. Europe Molecular Influenza Diagnostic Revenue and Growth Rate (2015-2020)
Figure 27. Asia-Pacific Molecular Influenza Diagnostic Revenue and Growth Rate (2015-2020)
Figure 28. South America Molecular Influenza Diagnostic Revenue and Growth Rate (2015-2020)
Figure 29. Middle East and Africa Molecular Influenza Diagnostic Revenue and Growth Rate (2015-2020)
Figure 30. North America Molecular Influenza Diagnostic Revenue Market Share by Countries (2015-2020)
Figure 31. North America Molecular Influenza Diagnostic Revenue Market Share by Countries in 2019
Figure 32. USA Molecular Influenza Diagnostic Revenue and Growth Rate (2015-2020)
Figure 33. Canada Molecular Influenza Diagnostic Revenue and Growth Rate (2015-2020)
Figure 34. Mexico Molecular Influenza Diagnostic Revenue and Growth Rate (2015-2020)
Figure 35. Europe Molecular Influenza Diagnostic Revenue Market Share by Countries (2015-2020)
Figure 36. Europe Molecular Influenza Diagnostic Revenue Market Share by Countries in 2019
Figure 37. Germany Molecular Influenza Diagnostic Revenue and Growth Rate (2015-2020)
Figure 38. UK Molecular Influenza Diagnostic Revenue and Growth Rate (2015-2020)
Figure 39. France Molecular Influenza Diagnostic Revenue and Growth Rate (2015-2020)
Figure 40. Russia Molecular Influenza Diagnostic Revenue and Growth Rate (2015-2020)
Figure 41. Italy Molecular Influenza Diagnostic Revenue and Growth Rate (2015-2020)
Figure 42. Asia-Pacific Molecular Influenza Diagnostic Revenue Market Share by Countries (2015-2020)
Figure 43. Asia-Pacific Molecular Influenza Diagnostic Revenue Market Share by Countries in 2019
Figure 44. China Molecular Influenza Diagnostic Revenue and Growth Rate (2015-2020)
Figure 45. Japan Molecular Influenza Diagnostic Revenue and Growth Rate (2015-2020)
Figure 46. Korea Molecular Influenza Diagnostic Revenue and Growth Rate (2015-2020)
Figure 47. India Molecular Influenza Diagnostic Revenue and Growth Rate (2015-2020)
Figure 48. Southeast Asia Molecular Influenza Diagnostic Revenue and Growth Rate (2015-2020)
Figure 49. South America Molecular Influenza Diagnostic Revenue Market Share by Countries (2015-2020)
Figure 50. South America Molecular Influenza Diagnostic Revenue Market Share by Countries in 2019
Figure 51. Brazil Molecular Influenza Diagnostic Revenue and Growth Rate (2015-2020)
Figure 52. Argentina Molecular Influenza Diagnostic Revenue and Growth Rate (2015-2020)
Figure 53. Middle East and Africa Molecular Influenza Diagnostic Revenue Market Share by Countries (2015-2020)
Figure 54. Middle East and Africa Molecular Influenza Diagnostic Revenue Market Share by Countries in 2019
Figure 55. Saudi Arabia Molecular Influenza Diagnostic Revenue and Growth Rate (2015-2020)
Figure 56. UAE Molecular Influenza Diagnostic Revenue and Growth Rate (2015-2020)
Figure 57. Egypt Molecular Influenza Diagnostic Revenue and Growth Rate (2015-2020)
Figure 58. South Africa Molecular Influenza Diagnostic Revenue and Growth Rate (2015-2020)
Figure 59. Global Molecular Influenza Diagnostic Revenue Share by Type (2015-2020)
Figure 60. Global Molecular Influenza Diagnostic Revenue Share by Type in 2019
Figure 61. Global Molecular Influenza Diagnostic Market Share Forecast by Type (2021-2025)
Figure 62. Global Reverse Transcription Polymerase Chain Reaction (RT-PCR) Revenue Growth Rate (2015-2020)
Figure 63. Global Nucleic Acid Sequence Based Amplification (NASBA) Tests Revenue Growth Rate (2015-2020)
Figure 64. Global Loop-mediated Isothermal Amplification-Based Assays (LAMP) Revenue Growth Rate (2015-2020)
Figure 65. Global Simple Amplification-based Assays (SAMBA) Revenue Growth Rate (2015-2020)
Figure 66. Global Molecular Influenza Diagnostic Revenue Share by Application (2015-2020)
Figure 67. Global Molecular Influenza Diagnostic Revenue Share by Application in 2019
Figure 68. Global Molecular Influenza Diagnostic Market Share Forecast by Application (2021-2025)
Figure 69. Global Hospitals Revenue Growth Rate (2015-2020)
Figure 70. Global POCT Revenue Growth Rate (2015-2020)
Figure 71. Global Others Revenue Growth Rate (2015-2020)
Figure 72. Global Molecular Influenza Diagnostic Revenue (Million USD) and Growth Rate Forecast (2021-2025)
Figure 73. Global Molecular Influenza Diagnostic Revenue (Million USD) Forecast by Regions (2021-2025)
Figure 74. Global Molecular Influenza Diagnostic Revenue Market Share Forecast by Regions (2021-2025)
Figure 75. North America Molecular Influenza Diagnostic Revenue Market Forecast (2021-2025)
Figure 76. Europe Molecular Influenza Diagnostic Revenue Market Forecast (2021-2025)
Figure 77. Asia-Pacific Molecular Influenza Diagnostic Revenue Market Forecast (2021-2025)
Figure 78. South America Molecular Influenza Diagnostic Revenue Market Forecast (2021-2025)
Figure 79. Middle East and Africa Molecular Influenza Diagnostic Revenue Market Forecast (2021-2025)
Figure 80. Sales Channel: Direct Channel vs Indirect Channel

---